Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis

By sjmartinez • February 28, 2023

Kuraji R, Shiba T, Dong TS, Numabe Y, Kapila YL. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis. World J Gastroenterol. 2023 Feb 14;29(6):967-996. doi: 10.3748/wjg.v29.i6.967. PMID: 36844143; PMCID: PMC9950865.

Tags: Digestive Diseases, Dysbiosis, Metabolic syndrome, Microbiota, Nonalcoholic fatty liver disease, Periodontal disease, probiotics, Publications

One in 4 transplant hepatologists in the United States screens positive for unhealthy alcohol use

Coe C, Prause N, Benhammou JN, Singh J, Shetty A, Trivedi HD, Yanny B, Shoptaw S, Pourmand K, Patel AA. One in 4 transplant hepatologists[...]

Physical activity and advanced fibrosis in MASLD, MetALD, and ALD in a nationally representative cohort: NHANES 2017-2020

Dunn N, Zhang W, Blaney HL, Diaz LA, Patel A, Wong RJ, Arab JP, Younossi Z, McClain C, Kong M, Singal AK. Physical activity and[...]

Research Communication: An Observational Cohort Study on Risk of Ovarian Cancer in Women with Irritable Bowel Syndrome

Shin A, Xu H, Sarnoff R, Church A, Chang L. Research Communication: An Observational Cohort Study on Risk of Ovarian Cancer in Women with Irritable[...]